Literature DB >> 16429914

Myoangiogenesis after cell patch cardiomyoplasty and omentopexy in a patient with ischemic cardiomyopathy.

Syde A Taheri1, Hasmat Ashraf, Michael Merhige, Robert S Miletich, Sateesh Satchidanand, Chetan Malik, John Naughton, Qiang Zhao.   

Abstract

We describe a procedure to promote angiogenesis and impregnation of skeletal myoblast into infarcted myocardium. At the completion of coronary artery bypass surgery, the midline sternotomy incision was extended to open the abdomen, and the greater omentum was tailored to reach the myocardium. Four pieces of autologous rectus muscle were applied to the infarcted left ventricle. This implantation was reinforced by the greater omentum. Incisions were closed in the usual manner. Postoperatively, the patient showed significant improvements in left ventricular ejection fraction (from 0.15 to 0.40) and in exercise tolerance (from 3 METs to 6 METs, or 100%). Computed tomographic angiography and positron emission tomography demonstrated improved myocardial viability and vascularity in the ischemic segments of the left ventricle. Omentopexy and cell patch cardiomyoplasty in conjunction with coronary artery bypass surgery may stimulate myogenesis and angiogenesis in avascular, dyskinetic scar tissue of left ventricle; in this preliminary study, this procedure appeared to improve the functional capacity of the left ventricle.

Entities:  

Mesh:

Year:  2005        PMID: 16429914      PMCID: PMC1351841     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  10 in total

1.  Synergistic approaches in the surgical treatment of heart failure: complex solutions for complex problems.

Authors:  Patrick M McCarthy
Journal:  Semin Thorac Cardiovasc Surg       Date:  2002-04

Review 2.  New surgical therapies for heart failure.

Authors:  Matthias Loebe; Ernesto Soltero; Vinay Thohan; Javier A Lafuente; George P Noon
Journal:  Curr Opin Cardiol       Date:  2003-05       Impact factor: 2.161

3.  Primary malignant fibrous histiocytoma of the greater omentum.

Authors:  S Aggarwal; S Haldar; A Kumar; S Kumar; S Guleria; R Dawar
Journal:  Trop Gastroenterol       Date:  2002 Oct-Dec

4.  Decision-making in end-stage coronary artery disease: revascularization or heart transplantation?

Authors:  H Hausmann; H Topp; H Siniawski; S Holz; R Hetzer
Journal:  Ann Thorac Surg       Date:  1997-11       Impact factor: 4.330

5.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.

Authors:  Philippe Menasché; Albert A Hagège; Jean-Thomas Vilquin; Michel Desnos; Eric Abergel; Bruno Pouzet; Alain Bel; Sorin Sarateanu; Marcio Scorsin; Ketty Schwartz; Patrick Bruneval; Marc Benbunan; Jean-Pierre Marolleau; Denis Duboc
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

Review 6.  Use of the greater omentum in colorectal surgery.

Authors:  D P O'Leary
Journal:  Dis Colon Rectum       Date:  1999-04       Impact factor: 4.585

7.  Omental transposition for cerebral infarction: a 13-year follow-up study.

Authors:  H S Goldsmith; D S Sax
Journal:  Surg Neurol       Date:  1999-03

8.  Myoblast transplantation for heart failure.

Authors:  P Menasché; A A Hagège; M Scorsin; B Pouzet; M Desnos; D Duboc; K Schwartz; J T Vilquin; J P Marolleau
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

9.  Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers.

Authors:  Keiichi Tambara; Yutaka Sakakibara; Genichi Sakaguchi; Fanglin Lu; Goditha U Premaratne; Xue Lin; Kazunobu Nishimura; Masashi Komeda
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

10.  Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).

Authors:  Christopher M O'Connor; Eric J Velazquez; Laura H Gardner; Peter K Smith; Mark F Newman; Kevin P Landolfo; Kerry L Lee; Robert M Califf; Robert H Jones
Journal:  Am J Cardiol       Date:  2002-07-15       Impact factor: 2.778

  10 in total
  6 in total

1.  Omental grafting: a cell-based therapy for blood vessel repair.

Authors:  Elaine L Shelton; Stanley D Poole; Jeff Reese; David M Bader
Journal:  J Tissue Eng Regen Med       Date:  2012-02-08       Impact factor: 3.963

2.  Geometric adaption of biodegradable magnesium alloy scaffolds to stabilise biological myocardial grafts. Part I.

Authors:  M Bauer; T Schilling; M Weidling; D Hartung; Ch Biskup; P Wriggers; F Wacker; Fr-W Bach; A Haverich; T Hassel
Journal:  J Mater Sci Mater Med       Date:  2013-11-22       Impact factor: 3.896

Review 3.  [Tissue engineering of vascularized myocardial prosthetic tissue. Biological and solid matrices].

Authors:  T Schilling; S Cebotari; I Tudorache; A Haverich
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

Review 4.  The current status of engineering myocardial tissue.

Authors:  Runqian Sui; Xiaobo Liao; Xinmin Zhou; Qi Tan
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

5.  Thymosin β4 mobilizes mesothelial cells for blood vessel repair.

Authors:  Elaine L Shelton; David M Bader
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

6.  Gene manipulated peritoneal cell patch repairs infarcted myocardium.

Authors:  Wei Huang; Dongsheng Zhang; Ronald W Millard; Tao Wang; Tiemin Zhao; Guo-Chang Fan; Atif Ashraf; Meifeng Xu; Muhammad Ashraf; Yigang Wang
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.